Overall, the identification of a KDM3A/KDM4B co-regulatory axis that regulates FOXA1 and subsequent ER deposition on chromatin in breast cancer enhances the understanding of the mechanisms controlling ER-transcriptional activity. Here, FOXA1 is linked to breast cancer.